BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17689832)

  • 1. Evaluating the role of recombinant erythropoietin in nephrogenic systemic fibrosis.
    Goveia M; Chan BP; Patel PR
    J Am Acad Dermatol; 2007 Oct; 57(4):725-7. PubMed ID: 17689832
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders.
    Cowper SE; Kuo PH; Bucala R
    Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160
    [No Abstract]   [Full Text] [Related]  

  • 3. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis: is any contrast safe in renal failure?
    Endre ZH
    Intern Med J; 2007 Jul; 37(7):429-31. PubMed ID: 17547720
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney disease.
    Perazella MA; Rodby RA
    Am J Med; 2007 Jul; 120(7):561-2. PubMed ID: 17602923
    [No Abstract]   [Full Text] [Related]  

  • 6. Epoetin and nephrogenic systemic fibrosis.
    Saab G
    J Am Acad Dermatol; 2008 Jan; 58(1):174-5. PubMed ID: 18158932
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrogenic systemic fibrosis: a clinicopathologic study of six cases.
    Pryor JG; Poggioli G; Galaria N; Gust A; Robison J; Samie F; Hanjani NM; Scott GA
    J Am Acad Dermatol; 2007 Jul; 57(1):105-11. PubMed ID: 17412451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB; Maize JC; Woolson RF; Budisavljevic MN
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic systemic fibrosis: a dermatologist's perspective.
    Girardi M
    J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C
    Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract]   [Full Text] [Related]  

  • 11. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
    Parsons AC; Yosipovitch G; Sheehan DJ; Sangüeza OP; Greenberg CS; Sane DC
    Am J Dermatopathol; 2007 Oct; 29(5):433-6. PubMed ID: 17890909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A; Greene JF; High WA
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis: an overview.
    Cowper SE
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P
    J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Weiss AS; Lucia MS; Teitelbaum I
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):111-5. PubMed ID: 17251999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium.
    Caccetta T; Chan JJ
    Australas J Dermatol; 2008 Feb; 49(1):48-51. PubMed ID: 18186850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic fibrosing dermopathy.
    Firoz BF; Hunzeker CM; Soldano AC; Franks AG
    Dermatol Online J; 2008 May; 14(5):11. PubMed ID: 18627747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case 35-2004: nephrogenic fibrosing dermopathy.
    Cowper SE; Bucala R; LeBoit PE
    N Engl J Med; 2005 Apr; 352(16):1723-4; author reply 1723-4. PubMed ID: 15846862
    [No Abstract]   [Full Text] [Related]  

  • 19. What nephrogenic fibrosing dermopathy might be.
    LeBoit PE
    Arch Dermatol; 2003 Jul; 139(7):928-30. PubMed ID: 12873893
    [No Abstract]   [Full Text] [Related]  

  • 20. Quiz page February 2008: A hemodialysis patient with thickened skin. Nephrogenic fibrosing dermopathy.
    Jan F; Mahboob H; Schwartz AB
    Am J Kidney Dis; 2008 Feb; 51(2):A33-4. PubMed ID: 18215691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.